This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Caltrate Double D Product Lineup

This August, up to 51 percent of Americans will take a summer vacation, but many women will take steps to shield themselves from the sun’s harmful ultraviolet (UV) rays. Direct exposure to sunlight is the primary source of vitamin D, an essential nutrient that maximizes the body’s absorption of calcium and helps support healthy bones, joints and muscles.* However, as the body ages, it becomes less efficient at producing vitamin D from the sun. Leading experts believe up to 77 percent of Americans have insufficient levels of vitamin D, thus increasing their risk for falls and fractures.

Common sun care practices such as using sunscreen and wearing hats are key to protecting the skin, but also block the body from absorbing the sunlight necessary to produce vitamin D. The American Academy of Dermatology recommends rather than increasing sun exposure, people obtain vitamin D through adequate diet or supplements.

A supplement, like Caltrate®, can help provide the daily nutritional requirements for vitamin D and calcium, if not already achieved through sun exposure and diet alone. Caltrate ® now with double the amount of vitamin D3, has more D than any other calcium supplement to help maximize calcium absorption. This helps women keep their bones strong, bodies healthy and moving throughout life.*

Caltrate® is purchased by more Americans than any other calcium supplement. Caltrate® helps women meet their recommended daily calcium and vitamin D requirements and, in conjunction with a healthy diet and exercise, supports healthy bones, joints and muscles.*

Always speak with a health care provider if you have concerns or questions regarding your personal health and to ask if supplements are right for you.

Media should contact Nicole Kaldes at Marina Maher Communications,(212) 485-6925 / for photos, video and additional information.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.64 -0.11%
FB $118.57 0.84%
GOOG $698.21 0.75%
TSLA $241.80 0.43%
YHOO $36.53 -0.19%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs